Skip to content

Clinical trials

Terminated Phase 3 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Terminated Country / region: Hong Kong Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20057
20064
200710
20085
20096
20108
20116
20128
20131
20144
20165
20176
201810
20193
20204
20219
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated105

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Pfizer10
Hoffmann-La Roche9
Amgen7
GlaxoSmithKline6
Gilead Sciences5
AstraZeneca4
Sanofi4
Alexion Pharmaceuticals, Inc.3
Bayer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung12
Diabetes Mellitus, Type 29
Neoplasms8
Carcinoma, Hepatocellular6
Crohn Disease6
Breast Neoplasms5
Ovarian Neoplasms4
Alzheimer Disease3
Cardiovascular Diseases3
Idiopathic Pulmonary Fibrosis3

Trials

Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.